Manuscripts and Posters

Systematic Reviews/Meta-Analysis

  1. Efficacy and Safety of Oxaliplatin/Capecitabine Based Chemotherapy Plus Bevacizumab as First-line Treatment for Advanced Colorectal Cancer: A Systematic Review and Meta analysis at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  2. Efficacy and Safety of Bevacizumab Plus Chemotherapy Versus Chemotherapy Alone in the Treatment of NSCLC in Asian Patients: A Systematic Review and Meta analysis at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  3. Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis. J Global Infect Dis 2016;8:32-40
  4. Cardiovascular Safety of Saxagliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review And Meta-analysis at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria
  5. Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta Analysis at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria
  6. Systematic Review and Meta-analysis of Risperidone for the Treatment of Schizophrenia at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria 
  7. Mepolizumab for the Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials at ISPOR 7th Asia-Pacific Conference, May 3-6, 2016, Singapore. 
  8. Efficacy and Safety of Dulaglutide in the Management of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA. 
  9. Systematic Review and Meta-analysis of Briakinumab, a Fully Human Interleukin 12/23 Monoclonal Antibody, for the Treatment of Moderate to Severe Chronic Plaque Psoriasis at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA. 
  10. Investigating the Value of Omalizumab in the Treatment of Severe Persistent Allergic Asthma: A Systematic Review of Cost- Effectiveness Studies at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA.  
  11. Current Pharmacological Treatment Options and Management of Guillain-Barre Syndrome (GBS): An Updated Systematic Review at 1st National Conference on Health Technology Assessment, 22nd January 2016 at Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  12. Efficacy and safety of canagliflozin among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Indian J Endocr Metab 2015;19:705-21
  13. Phytomedicine in the Treatment of Cancer: A Health Technology Assessment. J Clin Diagn Res. 2015 Dec; 9(12): XC04–XC09.
  14. Mammography for Breast Cancer Screening in India – A Health Technology Assessment at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  15. Comparison of T-piece Resuscitator with Other Flow – Inflating Bags for Providing Positive Pressure Ventilation During Neonatal Resuscitation: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  16. The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – a Health Technology Assessment at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  17. Impact of Socioeconomic Status on the Prevalence of Complications in Type 2 Diabetes in Indian Population: a Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  18. Risk of Fracture in Type 2 Diabetes Mellitus Patients: Meta-analysis of Observational Studies at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  19. Physical Functioning and Pain in Chronic Low Back Pain: A Systematic Review of Psychometric Properties of Various Outcomes Measures at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  20. The Impact Of Severe Asthma On The Quality Of Life: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  21. Epidemiology And Current Treatment Of Neuromyelitis Optica: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  22. Impact of Community Based Therapy on Children With Mental Health Disorders: A Health Technology Assessment at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  23. Efficacy And Safety Of Canagliflozin Among Patients With Type 2 Diabetes Mellitus: A Systematic Review And Meta-Analysis at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  24. The Prevalence of Age-related Macular Degeneration (AMD) in Indian Population: A Systematic Review at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  25. Association Between Bone Mineral Density and Type 1 Diabetes Mellitus: A Meta-analysis Of Observational Studies at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  26. Quality of Life in Neuromyelitis Optica: A Systematic Review at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 

Healthcare Use and Policy

  1. Taking Patients as Partners in Research at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  2. The Emerging Role of Patient Reported Outcomes (PROs) in Clinical Trials: An Indian Perspective. Value in Health 2017; 12:24-26
  3. Patient Advocacy and Changing Paradigm in Drug Access. Int J Med Public Health 2016;6:179-18
  4. Real world evidence: An Indian perspective. Perspect Clin Res 2016;7:156-60
  5. Can Health Technology Assessment (HTA) provide a solution to tackle the increasing health-care expenditure in India?. Indian J Public Health 2016;60:138-41
  6. The value of observational study data in healthcare decision making: An Indian perspective. Int J Med Public Health 2016;6:53-5
  7. Importance of Economic Evaluation in Health Care: An Indian Perspective. Value in Health Regional Issues. 2016;9:78-83
  8. Comparative effectiveness research and its utility in In-clinic practice. Perspect Clin Res 2016;7:9-14
  9. Improving Access to New Treatments with Value Based Pricing: An Indian Perspective. Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):1-5
  10. Stratified Medicine: Will it be the Future of Medicine? Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):11-14
  11. Patient Advocacy and Changing Paradigm in Drug Access at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA.  
  12. Patient Centric Clinical Trials – The Future of Clinical Trials at 9th Annual Conference of ISCR (Indian Society for Clinical Research) January 8th & 9th, 2016, Mumbai. 
  13. Utilizing Patient Registries as Health Technology Assessment (HTA) tool. Sys Rev Pharm 2015, 6 (1):5-8
  14. The Role of Patient Reported Outcomes (PROs) in Healthcare Policy Making. Sys Rev Pharm 2015, 6 (1):1-5
  15. The Value of Big Data in Clinical Decision Making. International Journal of Computer Science and Information Technologies, Vol. 6 (4) , 2015, 3830-3835
  16. The emerging role of patient-centered outcomes research in shaping the future of healthcare delivery in India: A brief review. Int J Med Public Health 2015;5:125-7
  17. Role of a medical advisor in pharmacovigilance as a business support service. Perspect Clin Res 2015;6:64-7
  18. How Insurance Claim Data can Help in Health Outcomes Research: An Indian Perspective at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  19. The Role of Patient Reported Outcomes (PROs) in Healthcare Policy Making at Fourth International Conference of Pharmacoecomomics & Outcomes Research. October 31 – November 1, 2015, New Delhi, India. 
  20. The Real World: How Integrated data can be used to improve patient care? at Indo-Global Healthcare Summit & Expo 2015. 23 – 26 July, 2015, Hyderabad, India. 
  21. Data-Based Medicine v/s Evidence Based Medicine at Indo-Global Healthcare Summit & Expo 2015. 23 – 26 July, 2015, Hyderabad, India. 
  22. The Emerging Role of Patient-Reported Outcomes (PROs) in Clinical Trials in India at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  23. Electronic Health Record System in India: Implications for Health Technology Assessment (HTA), Status and Challenges. The Pharma Review 2014; 72-74
  24. Health Technology Assessment (HTA): Status & Future Challenges in India at Third International Conference of Pharmacoecomomics & Outcomes Research 2014. October 17 & 18, 2014. Organized by: ISPOR India Chapter. 
  25. Understanding the Era of “Digital Patient”: Are we ready to Achieve Better Healthcare Outcomes? at Third International Conference of Pharmacoecomomics & Outcomes Research 2014. October 17 & 18, 2014. Organized by: ISPOR India Chapter (Plenary Lecture) 
  26. Management of Clinical Trials in India – Current Perspective and Way Forward. The Pharma Review. 2013: 95-100